Zotepine + Risperidone
ApprovedTerminated 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Schizophrenia
Conditions
Schizophrenia
Trial Timeline
Mar 1, 2007 → Dec 1, 2009
NCT ID
NCT00418873About Zotepine + Risperidone
Zotepine + Risperidone is a approved stage product being developed by Astellas Pharma for Schizophrenia. The current trial status is terminated. This product is registered under clinical trial identifier NCT00418873. Target conditions include Schizophrenia.
What happened to similar drugs?
20 of 20 similar drugs in Schizophrenia were approved
Approved (20) Terminated (1) Active (0)
Hype Score Breakdown
Clinical
20
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00418873 | Approved | Terminated |
Competing Products
20 competing products in Schizophrenia